Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

Learn more about whether Moderna, Inc. or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor ...

AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...

At ESCMID Global 2025 in Vienna, AstraZeneca will present a comprehensive data package from its Vaccines & Immune Therapies portfolio, featur ...

Market OverviewThe global Vaccines Market has evolved significantly in recent years, driven by advancements in biotechnology, ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The US drug regulator has missed a deadline for granting full approval to Novavax’s Covid-19 vaccine, the company said Wednesday, amid major shakeups at health agencies under President Donald Trump.

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...

Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), an mRNA ...